ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

OCUL Ocular Therapeutix Inc

5,70
-0,10 (-1,72%)
01 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Ocular Therapeutix Inc OCUL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,10 -1,72% 5,70 01:39:56
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,94 5,62 6,01 5,70 5,80
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.5.202423:17EDGAR2Form 144 - Report of proposed sale of securities
29.5.202422:33EDGAR2Form 144 - Report of proposed sale of securities
28.5.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.5.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.5.202422:18EDGAR2Form 144 - Report of proposed sale of securities
23.5.202422:16EDGAR2Form 144 - Report of proposed sale of securities
07.5.202422:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
07.5.202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.5.202422:05GLOBEOcular Therapeutix™ Reports First Quarter 2024 Results
07.5.202422:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07.5.202402:16GLOBEOcular Therapeutix Reports Inducement Grants Under Nasdaq..
06.5.202413:30GLOBEOcular Therapeutix™ to Present at Two Upcoming Investor..
03.5.202413:30GLOBEOcular Therapeutix™ To Present at Two Ophthalmology..
01.5.202413:30GLOBEOcular Therapeutix™ to Host Investor Day in New York City on..
11.3.202421:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
11.3.202421:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11.3.202421:10EDGAR2Form 8-K - Current report
11.3.202411:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
27.2.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202402:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
27.2.202402:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
22.2.202414:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
22.2.202413:34EDGAR2Form 8-K - Current report
19.2.202415:00PRNUSAffaMed Therapeutics Announces New Drug Application..
15.2.202414:00GLOBEOcular Therapeutix™ Appoints Steve Meyers to Chief..
15.2.202401:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202413:37GLOBEOcular Therapeutix™ Announces First Subjects Screened in..
07.2.202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202422:41EDGAR2Form 144 - Report of proposed sale of securities
05.2.202422:39EDGAR2Form 144 - Report of proposed sale of securities
05.2.202422:36EDGAR2Form 144 - Report of proposed sale of securities
05.2.202422:33EDGAR2Form 144 - Report of proposed sale of securities
05.2.202422:30EDGAR2Form 144 - Report of proposed sale of securities
03.2.202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202423:41EDGAR2Form 144 - Report of proposed sale of securities
31.1.202423:39EDGAR2Form 144 - Report of proposed sale of securities
31.1.202423:36EDGAR2Form 144 - Report of proposed sale of securities
31.1.202423:34EDGAR2Form 144 - Report of proposed sale of securities
31.1.202423:31EDGAR2Form 144 - Report of proposed sale of securities
25.1.202414:04EDGAR2Form 8-K - Current report